Literature DB >> 11814678

Effects of mouse strain, position of integration and tetracycline analogue on the tetracycline conditional system in transgenic mice.

Andrea Robertson1, Javier Perea, Tanya Tolmachova, P K Thomas, Clare Huxley.   

Abstract

The tetracycline conditional system is a very powerful method for achieving control of gene expression in transgenic mice, allowing one to turn expression both off and on in the same animal. We have used it to make a tissue-specific transgenic mouse model of Charcot-Marie-Tooth disease type 1A. This disease is most commonly caused by overexpression of peripheral myelin protein 22 (PMP22) in Schwann cells of the peripheral nervous system. Here we describe the effects of position of integration of the transgene, tetracycline analogue and mouse strain in this model. The small transgenes used to express tTA, the LacZ reporter and the pmp22 cDNA were all very dependent on the position of integration with few of the transgenic lines working successfully. In contrast, the single transgenic made with the 560 kb yeast artificial chromosome construct containing the tTA open reading frame worked well. Tetracycline was found to be cleared from mice relatively fast in comparison with doxycycline and is thus useful if one wants to switch on gene expression after extended periods of administration. Finally, the initial litters were on a mixed genetic background and the level of LacZ or pmp22 expression was very variable between mice. We found that expression became uniform between mice, and occurred in a higher proportion of cells, when the transgenes were crossed onto the CBA/Ca background in comparison with the C57BL/6J background.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11814678     DOI: 10.1016/s0378-1119(01)00793-4

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  18 in total

1.  Cardiac-specific NRAP overexpression causes right ventricular dysfunction in mice.

Authors:  Shajia Lu; Garland L Crawford; Justin Dore; Stasia A Anderson; Daryl Despres; Robert Horowits
Journal:  Exp Cell Res       Date:  2011-01-26       Impact factor: 3.905

2.  Standing genetic variation and compensatory evolution in transgenic organisms: a growth-enhanced salmon simulation.

Authors:  Robert N M Ahrens; Robert H Devlin
Journal:  Transgenic Res       Date:  2010-09-29       Impact factor: 2.788

3.  Applying an Inducible Expression System to Study Interference of Bacterial Virulence Factors with Intracellular Signaling.

Authors:  Christian Berens; Stephanie Bisle; Leonie Klingenbeck; Anja Lührmann
Journal:  J Vis Exp       Date:  2015-06-25       Impact factor: 1.355

4.  A general approach for controlling transcription and probing epigenetic mechanisms: application to the CD4 locus.

Authors:  Mimi Wan; Ravinder Kaundal; Haichang Huang; Jiugang Zhao; Xiaojun Yang; Barbara H Chaiyachati; Sicong Li; Tian Chi
Journal:  J Immunol       Date:  2013-01-15       Impact factor: 5.422

5.  Differential Neurotoxicity Related to Tetracycline Transactivator and TDP-43 Expression in Conditional TDP-43 Mouse Model of Frontotemporal Lobar Degeneration.

Authors:  L Kukreja; R Shahidehpour; G Kim; J Keegan; K R Sadleir; T Russell; J Csernansky; M Mesulam; R J Vassar; L Wang; H Dong; C Geula
Journal:  J Neurosci       Date:  2018-05-28       Impact factor: 6.167

6.  Transgene expression in the Nop-tTA driver line is not inherently restricted to the entorhinal cortex.

Authors:  Michael J Yetman; Sveinung Lillehaug; Jan G Bjaalie; Trygve B Leergaard; Joanna L Jankowsky
Journal:  Brain Struct Funct       Date:  2015-04-14       Impact factor: 3.270

7.  Identification of the variant Ala335Val of MED25 as responsible for CMT2B2: molecular data, functional studies of the SH3 recognition motif and correlation between wild-type MED25 and PMP22 RNA levels in CMT1A animal models.

Authors:  Alejandro Leal; Kathrin Huehne; Finn Bauer; Heinrich Sticht; Philipp Berger; Ueli Suter; Bernal Morera; Gerardo Del Valle; James R Lupski; Arif Ekici; Francesca Pasutto; Sabine Endele; Ramiro Barrantes; Corinna Berghoff; Martin Berghoff; Bernhard Neundörfer; Dieter Heuss; Thomas Dorn; Peter Young; Lisa Santolin; Thomas Uhlmann; Michael Meisterernst; Michael Werner Sereda; Michael Sereda; Ruth Martha Stassart; Gerd Meyer zu Horste; Klaus-Armin Nave; André Reis; Bernd Rautenstrauss
Journal:  Neurogenetics       Date:  2009-03-17       Impact factor: 2.660

8.  Inducible cardiomyocyte-specific gene disruption directed by the rat Tnnt2 promoter in the mouse.

Authors:  Bingruo Wu; Bin Zhou; Yidong Wang; Hsiu-Ling Cheng; Calvin T Hang; William T Pu; Ching-Pin Chang; Bin Zhou
Journal:  Genesis       Date:  2010-01       Impact factor: 2.487

9.  Tetracycline-inducible system for regulation of skeletal muscle-specific gene expression in transgenic mice.

Authors:  Mischala A Grill; Mark A Bales; Amber N Fought; Kristopher C Rosburg; Stephanie J Munger; Parker B Antin
Journal:  Transgenic Res       Date:  2003-02       Impact factor: 2.788

10.  Strain background influences neurotoxicity and behavioral abnormalities in mice expressing the tetracycline transactivator.

Authors:  Harry J Han; Carolyn C Allen; Christie M Buchovecky; Michael J Yetman; Heather A Born; Miguel A Marin; Shaefali P Rodgers; Bryan J Song; Hui-Chen Lu; Monica J Justice; Frank J Probst; Joanna L Jankowsky
Journal:  J Neurosci       Date:  2012-08-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.